Boris Naraev, an expert in gastrointestinal, neuroendocrine, and endocrine tumors, joined the Tampa General Hospital Cancer Institute and was appointed as associate professor in the Department of Internal Medicine at the University of South Florida Health Morsani College of Medicine.
Daniel K. Nomura was named editor-in-chief of Molecular Cancer Therapeutics, one of the 10 journals published by the American Association for Cancer Research.
Case Comprehensive Cancer Center was recognized by NCI with a merit award of “outstanding,” 19 months after transitioning to a new director.
Children’s National Hospital and Virginia Tech are expanding their research partnership, building on a successful collaboration established in 2019.
The Stephenson Global Pancreatic Cancer Research Institute is creating new awards to advance pancreatic cancer research.
Pfizer Inc. announced positive results from the phase III TALAPRO-2 study of Talzenna (talazoparib), an oral poly ADP-ribose polymerase inhibitor, in combination with Xtandi (enzalutamide), an androgen receptor pathway inhibitor, demonstrating a statistically significant and clinically meaningful improvement in overall survival compared to placebo plus Xtandi in patients with metastatic castration-resistant prostate cancer, with or without homologous recombination repair gene mutations.
Interim analysis of a clinical trial led by Fox Chase Cancer Center researchers shows promise for the treatment of patients with muscle-invasive bladder cancer.
Experiencing pain may increase the odds that cancer survivors will use cigarettes and cannabis, according to a recent study published by Wiley online in CANCER, a peer-reviewed journal of ACS.
University of Virginia Cancer Center researchers explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.
Cortechs.ai and EDAP TMS SA announced the successful completion of the world’s first OnQ Prostate-assisted Focal One Robotic HIFU procedure at the University of California, San Francisco Prostate Center.
